The Role of Patients' Age on Their Preferences for Choosing Additional Blood Pressure-Lowering Drugs: A Discrete Choice Experiment in Patients with Diabetes.

To assess whether patients' willingness to add a blood pressure-lowering drug and the importance they attach to specific treatment characteristics differ among age groups in patients with type 2 diabetes.Patients being prescribed at least an oral glucose-lowering and a blood pressure-lowering d...

Full description

Bibliographic Details
Main Authors: Sieta T de Vries, Folgerdiena M de Vries, Thijs Dekker, Flora M Haaijer-Ruskamp, Dick de Zeeuw, Adelita V Ranchor, Petra Denig
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2015-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC4596700?pdf=render
id doaj-cee654b72e5a4bc999ed7b05fd9193da
record_format Article
spelling doaj-cee654b72e5a4bc999ed7b05fd9193da2020-11-25T00:49:13ZengPublic Library of Science (PLoS)PLoS ONE1932-62032015-01-011010e013975510.1371/journal.pone.0139755The Role of Patients' Age on Their Preferences for Choosing Additional Blood Pressure-Lowering Drugs: A Discrete Choice Experiment in Patients with Diabetes.Sieta T de VriesFolgerdiena M de VriesThijs DekkerFlora M Haaijer-RuskampDick de ZeeuwAdelita V RanchorPetra DenigTo assess whether patients' willingness to add a blood pressure-lowering drug and the importance they attach to specific treatment characteristics differ among age groups in patients with type 2 diabetes.Patients being prescribed at least an oral glucose-lowering and a blood pressure-lowering drug completed a questionnaire including a discrete choice experiment. This experiment contained choice sets with hypothetical blood pressure-lowering drugs and a no additional drug alternative, which differed in their characteristics (i.e. effects and intake moments). Differences in willingness to add a drug were compared between patients <75 years (non-aged) and ≥75 years (aged) using Pearson χ²-tests. Multinomial logit models were used to assess and compare the importance attached to the characteristics.Of the 161 patients who completed the questionnaire, 151 (72%) could be included in the analyses (mean age 68 years; 42% female). Aged patients were less willing to add a drug than non-aged patients (67% versus 84% respectively; P = 0.017). In both age groups, the effect on blood pressure was most important for choosing a drug, followed by the risk of adverse drug events and the risk of death. The effect on limitations due to stroke was only significant in the non-aged group. The effect on blood pressure was slightly more important in the non-aged than the aged group (P = 0.043).Aged patients appear less willing to add a preventive drug than non-aged patients. The importance attached to various treatment characteristics does not seem to differ much among age groups.http://europepmc.org/articles/PMC4596700?pdf=render
collection DOAJ
language English
format Article
sources DOAJ
author Sieta T de Vries
Folgerdiena M de Vries
Thijs Dekker
Flora M Haaijer-Ruskamp
Dick de Zeeuw
Adelita V Ranchor
Petra Denig
spellingShingle Sieta T de Vries
Folgerdiena M de Vries
Thijs Dekker
Flora M Haaijer-Ruskamp
Dick de Zeeuw
Adelita V Ranchor
Petra Denig
The Role of Patients' Age on Their Preferences for Choosing Additional Blood Pressure-Lowering Drugs: A Discrete Choice Experiment in Patients with Diabetes.
PLoS ONE
author_facet Sieta T de Vries
Folgerdiena M de Vries
Thijs Dekker
Flora M Haaijer-Ruskamp
Dick de Zeeuw
Adelita V Ranchor
Petra Denig
author_sort Sieta T de Vries
title The Role of Patients' Age on Their Preferences for Choosing Additional Blood Pressure-Lowering Drugs: A Discrete Choice Experiment in Patients with Diabetes.
title_short The Role of Patients' Age on Their Preferences for Choosing Additional Blood Pressure-Lowering Drugs: A Discrete Choice Experiment in Patients with Diabetes.
title_full The Role of Patients' Age on Their Preferences for Choosing Additional Blood Pressure-Lowering Drugs: A Discrete Choice Experiment in Patients with Diabetes.
title_fullStr The Role of Patients' Age on Their Preferences for Choosing Additional Blood Pressure-Lowering Drugs: A Discrete Choice Experiment in Patients with Diabetes.
title_full_unstemmed The Role of Patients' Age on Their Preferences for Choosing Additional Blood Pressure-Lowering Drugs: A Discrete Choice Experiment in Patients with Diabetes.
title_sort role of patients' age on their preferences for choosing additional blood pressure-lowering drugs: a discrete choice experiment in patients with diabetes.
publisher Public Library of Science (PLoS)
series PLoS ONE
issn 1932-6203
publishDate 2015-01-01
description To assess whether patients' willingness to add a blood pressure-lowering drug and the importance they attach to specific treatment characteristics differ among age groups in patients with type 2 diabetes.Patients being prescribed at least an oral glucose-lowering and a blood pressure-lowering drug completed a questionnaire including a discrete choice experiment. This experiment contained choice sets with hypothetical blood pressure-lowering drugs and a no additional drug alternative, which differed in their characteristics (i.e. effects and intake moments). Differences in willingness to add a drug were compared between patients <75 years (non-aged) and ≥75 years (aged) using Pearson χ²-tests. Multinomial logit models were used to assess and compare the importance attached to the characteristics.Of the 161 patients who completed the questionnaire, 151 (72%) could be included in the analyses (mean age 68 years; 42% female). Aged patients were less willing to add a drug than non-aged patients (67% versus 84% respectively; P = 0.017). In both age groups, the effect on blood pressure was most important for choosing a drug, followed by the risk of adverse drug events and the risk of death. The effect on limitations due to stroke was only significant in the non-aged group. The effect on blood pressure was slightly more important in the non-aged than the aged group (P = 0.043).Aged patients appear less willing to add a preventive drug than non-aged patients. The importance attached to various treatment characteristics does not seem to differ much among age groups.
url http://europepmc.org/articles/PMC4596700?pdf=render
work_keys_str_mv AT sietatdevries theroleofpatientsageontheirpreferencesforchoosingadditionalbloodpressureloweringdrugsadiscretechoiceexperimentinpatientswithdiabetes
AT folgerdienamdevries theroleofpatientsageontheirpreferencesforchoosingadditionalbloodpressureloweringdrugsadiscretechoiceexperimentinpatientswithdiabetes
AT thijsdekker theroleofpatientsageontheirpreferencesforchoosingadditionalbloodpressureloweringdrugsadiscretechoiceexperimentinpatientswithdiabetes
AT floramhaaijerruskamp theroleofpatientsageontheirpreferencesforchoosingadditionalbloodpressureloweringdrugsadiscretechoiceexperimentinpatientswithdiabetes
AT dickdezeeuw theroleofpatientsageontheirpreferencesforchoosingadditionalbloodpressureloweringdrugsadiscretechoiceexperimentinpatientswithdiabetes
AT adelitavranchor theroleofpatientsageontheirpreferencesforchoosingadditionalbloodpressureloweringdrugsadiscretechoiceexperimentinpatientswithdiabetes
AT petradenig theroleofpatientsageontheirpreferencesforchoosingadditionalbloodpressureloweringdrugsadiscretechoiceexperimentinpatientswithdiabetes
AT sietatdevries roleofpatientsageontheirpreferencesforchoosingadditionalbloodpressureloweringdrugsadiscretechoiceexperimentinpatientswithdiabetes
AT folgerdienamdevries roleofpatientsageontheirpreferencesforchoosingadditionalbloodpressureloweringdrugsadiscretechoiceexperimentinpatientswithdiabetes
AT thijsdekker roleofpatientsageontheirpreferencesforchoosingadditionalbloodpressureloweringdrugsadiscretechoiceexperimentinpatientswithdiabetes
AT floramhaaijerruskamp roleofpatientsageontheirpreferencesforchoosingadditionalbloodpressureloweringdrugsadiscretechoiceexperimentinpatientswithdiabetes
AT dickdezeeuw roleofpatientsageontheirpreferencesforchoosingadditionalbloodpressureloweringdrugsadiscretechoiceexperimentinpatientswithdiabetes
AT adelitavranchor roleofpatientsageontheirpreferencesforchoosingadditionalbloodpressureloweringdrugsadiscretechoiceexperimentinpatientswithdiabetes
AT petradenig roleofpatientsageontheirpreferencesforchoosingadditionalbloodpressureloweringdrugsadiscretechoiceexperimentinpatientswithdiabetes
_version_ 1725252343629348864